Quantcast
Last updated on April 24, 2014 at 12:21 EDT

Latest Psoriasis Stories

2013-10-07 08:25:59

Be Joint Smart educates public about disease affecting 500,000 NYC Metro residents PORTLAND, Ore., Oct. 7, 2013 /PRNewswire-USNewswire/ -- For the second year, the National Psoriasis Foundation and the Arthritis Foundation will partner to educate Americans about psoriatic arthritis, a chronic, inflammatory autoimmune disease that affects roughly 500,000 New York Metro residents. The two organizations present the first psoriatic-arthritis specific program in New York City--Be Joint Smart--at...

2013-10-03 08:30:25

Clinical Studies Show Skin's Moisture Improvement in Three Days MONTGOMERYVILLE, Pa., Oct. 3, 2013 /PRNewswire/ -- PhotoMedex (NasdaqGS and TASE: PHMD), the leader in photodamage repair technology, clinical skincare and medical laser products for more than a decade, introduces NEOVA(®) SmartSkinCare brand's DNA Barrier Accelerator, a hyper-active moisturizer that rehabilitates and fortifies the skin's essential protective barrier. DNA Barrier Accelerator is available for purchase in...

2013-10-03 00:20:13

THOUSAND OAKS, Calif. and GAITHERSBURG, Md., Oct. 3, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and AstraZeneca (AZN), with its biologics research and development arm MedImmune, today announced the upcoming presentation of several key studies evaluating brodalumab, a human monoclonal antibody targeting the interleukin-17 (IL-17) receptor, for the treatment of moderate to severe psoriasis at the 22(nd) Congress of the European Academy of Dermatology and Venereology (EADV) in Istanbul, Oct....

2013-10-01 08:32:06

Be Joint Smart educates public about devastating disease affecting 100,000 Pennsylvanians PORTLAND, Ore., Oct. 1, 2013 /PRNewswire-USNewswire/ -- For the second year, the National Psoriasis Foundation and the Arthritis Foundation will partner to educate Americans about psoriatic arthritis, a chronic, inflammatory autoimmune disease that affects roughly 100,000 Pennsylvanians and about 45,000 Philadelphia Metro residents. The two organizations present the first psoriatic-arthritis specific...

2013-09-30 08:28:39

- Approval is supported by data from the RAPID(TM)-PsA study and represents the third U.S. indication for Cimzia® BRUSSELS, Sept. 30, 2013 /PRNewswire/ -- regulated information - UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Cimzia(® )(certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis (PsA). "The FDA's approval of Cimzia(®) for the treatment of active PsA provides an additional, effective treatment option for those...

2013-09-27 10:12:13

Scientists at The Scripps Research Institute (TSRI) have discovered an important process by which special immune cells in the skin help heal wounds. They found that these skin-resident immune cells function as “first responders” to skin injuries in part by producing the molecule known as interleukin-17A (IL-17A), which wards off infection and promotes wound healing. “This appears to be a critical and unique component of mammals’ defense against skin wounds, and we hope that it will...

2013-09-24 23:40:04

Botox has been at the forefront of skin rejuvenation for over a decade. Besides the conventional uses of Botox, Southwest Skin and Cancer Institute is utilizing this versatile drug to aid in the treatment of several medical conditions. Prescott, AZ (PRWEB) September 24, 2013 Since 2002, Botox has been used to reduce the appearance of fine lines and wrinkles around the brow, forehead, chin, crow’s feet and neck. These creases often create a tired or stressed appearance which can be...

2013-09-23 08:28:09

First and Only Anti-IL-12/23 Treatment Approved for Adult Patients Living with Psoriatic Arthritis HORSHAM, Pa., Sept. 23, 2013 /PRNewswire/ -- Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved STELARA(®) (ustekinumab) alone or in combination with methotrexate for the treatment of adult patients (18 years or older) with active psoriatic arthritis. It is estimated that more than two million people in the U.S. are living with psoriatic...

2013-09-20 23:00:09

Best treatment for psoriasis review is now posted online at the http://ehealthmax.com/blog/best-treatment-psoriasis company. This review explores the natural products that are offered for men and women covering up the redness and flaking caused by psoriasis. Columbus, Ohio (PRWEB) September 21, 2013 Millions of American men and women suffer from skin conditions like psoriasis and frequently seek ways to reduce or eliminate the appearance of redness. The eHealthMax.com company has now...

2013-09-18 08:31:05

Be Joint Smart educates public about devastating disease affecting 300,000 Californians PORTLAND, Ore., Sept. 18, 2013 /PRNewswire-USNewswire/ -- For the second year, the National Psoriasis Foundation and the Arthritis Foundation will partner to educate Americans about psoriatic arthritis, a chronic, inflammatory autoimmune disease that affects roughly 300,000 Californians and about 98,000 Greater Los Angeles residents. The two organizations will present the first psoriatic-arthritis...